Elekta - neuer Threadversuch - 500 Beiträge pro Seite
eröffnet am 29.06.16 16:27:08 von
neuester Beitrag 28.07.19 11:34:11 von
neuester Beitrag 28.07.19 11:34:11 von
Beiträge: 5
ID: 1.234.417
ID: 1.234.417
Aufrufe heute: 0
Gesamt: 609
Gesamt: 609
Aktive User: 0
ISIN: SE0000163628 · WKN: 896279 · Symbol: EJXB
4,7660
EUR
-1,69 %
-0,0820 EUR
Letzter Kurs 09:30:10 Tradegate

Neuigkeiten
Titel |
---|
16.05.25 Bollinger Ausbruch nach oben |
03.03.25 · Markt Bote |
11.12.24 · PR Newswire (engl.) |
16.10.24 · PR Newswire (engl.) |
Werte aus der Branche Gesundheitswesen
Wertpapier | Kurs | Perf. % |
---|---|---|
6,0000 | +99.999,00 | |
6,0000 | +93,55 | |
6,1500 | +75,21 | |
2,0400 | +39,73 | |
0,5950 | +34,01 |
Wertpapier | Kurs | Perf. % |
---|---|---|
6,0900 | -13,62 | |
103,50 | -14,81 | |
2,5400 | -17,80 | |
1,2504 | -13,17 | |
0,6136 | -14,07 |
Begriffe und/oder Benutzer
Top-Postings
Ja Nein
nachdem der alte eingeschlafen ist; Thread: Elekta Risiken und Bewertung
hierüber drauf gestoßen:
Investment idea: Elekta
http://www.marketfolly.com/2016/06/alex-morozov-long-elekta-…
Elekta is a Sweden based company specialising in making radio therapy machines for patients with cancer. It’s not new technology but it is effective. Expect secular growth outside the US in radio therapy – 4-6% per year. Current guidelines call for radio therapy in 50% of cancer patients and the incidence of cancer is going up.
Elekta has a wide moat – there are two main players, Electa and Varian, that make radio therapy machines now that Siemens has exited the market.
Intangible assets: IP, brands, chemical databases, R&D productivity.
Switching costs: clinical relationships, there is a large installed base in large hospitals, re-training. Aftermarket sales provide a lucrative revenue stream.
The share price has pulled back due to a slowdown in order growth, software issues, change of CEO, poor cash flow conversion. The company has been known to use aggressive accounting practices. R&D expenditure has been high. Margins have bottomed and cash flow is improving. Valuation is attractive but patience will be required.
Read more: http://www.marketfolly.com/2016/06/alex-morozov-long-elekta-…
hierüber drauf gestoßen:
Investment idea: Elekta
http://www.marketfolly.com/2016/06/alex-morozov-long-elekta-…
Elekta is a Sweden based company specialising in making radio therapy machines for patients with cancer. It’s not new technology but it is effective. Expect secular growth outside the US in radio therapy – 4-6% per year. Current guidelines call for radio therapy in 50% of cancer patients and the incidence of cancer is going up.
Elekta has a wide moat – there are two main players, Electa and Varian, that make radio therapy machines now that Siemens has exited the market.
Intangible assets: IP, brands, chemical databases, R&D productivity.
Switching costs: clinical relationships, there is a large installed base in large hospitals, re-training. Aftermarket sales provide a lucrative revenue stream.
The share price has pulled back due to a slowdown in order growth, software issues, change of CEO, poor cash flow conversion. The company has been known to use aggressive accounting practices. R&D expenditure has been high. Margins have bottomed and cash flow is improving. Valuation is attractive but patience will be required.
Read more: http://www.marketfolly.com/2016/06/alex-morozov-long-elekta-…
immerhin von 6,50 auf 8,50 in einem Jahr
Antwort auf Beitrag Nr.: 55.076.800 von R-BgO am 04.06.17 12:04:09und jetzt 10,40
Antwort auf Beitrag Nr.: 57.893.034 von R-BgO am 02.06.18 15:32:06
Sieht mir nach einer Einstiegsmöglichkeit aus, nach den Zahlen, wenn man den Management Porgnosen trauen kann. Wie seriös / konservativ sind hier die Voraussagen?
Zahlen von heute
https://www.elekta.com/meta/press-all.html?id=84CA9E64F43C17…Sieht mir nach einer Einstiegsmöglichkeit aus, nach den Zahlen, wenn man den Management Porgnosen trauen kann. Wie seriös / konservativ sind hier die Voraussagen?
aktuelles KGV > 40
Beitrag zu dieser Diskussion schreiben
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
-1,46 | |
-0,32 | |
-1,20 | |
-2,24 | |
-2,27 | |
-1,37 | |
-0,34 | |
-2,24 | |
+2,09 | |
-2,10 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
144 | ||
30 | ||
26 | ||
17 | ||
15 | ||
15 | ||
13 | ||
11 | ||
10 | ||
9 |
Elekta - neuer Threadversuch